| Primary |
| Diabetes Mellitus |
29.3% |
| Drug Use For Unknown Indication |
13.0% |
| Hypertension |
11.5% |
| Product Used For Unknown Indication |
7.2% |
| Type 2 Diabetes Mellitus |
6.7% |
| Diabetes Mellitus Non-insulin-dependent |
5.3% |
| Helicobacter Infection |
4.3% |
| Blood Pressure Increased |
3.8% |
| Diabetes Mellitus Management |
2.9% |
| Essential Hypertension |
2.9% |
| Epilepsy |
1.9% |
| Angina Pectoris |
1.4% |
| Blood Glucose Increased |
1.4% |
| Dementia |
1.4% |
| Depression |
1.4% |
| Neutropenia |
1.4% |
| Atrial Fibrillation |
1.0% |
| Cerebral Infarction |
1.0% |
| Convulsion |
1.0% |
| Hepatic Cirrhosis |
1.0% |
|
| Hypoglycaemia |
28.1% |
| Renal Failure |
10.9% |
| Hypoglycaemic Encephalopathy |
6.3% |
| Tremor |
6.3% |
| Melaena |
4.7% |
| Pancreatitis Acute |
4.7% |
| Pemphigoid |
4.7% |
| Renal Failure Acute |
4.7% |
| Sarcoidosis |
4.7% |
| Weight Decreased |
4.7% |
| Anaphylactoid Shock |
3.1% |
| Hypoglycaemic Unconsciousness |
3.1% |
| Visual Impairment |
3.1% |
| Anaemia |
1.6% |
| Aplastic Anaemia |
1.6% |
| Cardiac Failure |
1.6% |
| Dermatitis Exfoliative |
1.6% |
| Drug Interaction |
1.6% |
| Hydrocephalus |
1.6% |
| Hypoglycaemic Coma |
1.6% |
|
| Secondary |
| Diabetes Mellitus |
17.8% |
| Drug Use For Unknown Indication |
17.8% |
| Type 2 Diabetes Mellitus |
16.0% |
| Hypertension |
13.5% |
| Product Used For Unknown Indication |
7.5% |
| Diabetes Mellitus Non-insulin-dependent |
3.9% |
| Gastritis |
3.2% |
| Blood Glucose Increased |
2.1% |
| Unevaluable Event |
2.1% |
| Angina Pectoris |
1.8% |
| Essential Hypertension |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Multiple Myeloma |
1.8% |
| Prostate Cancer |
1.8% |
| Dyslipidaemia |
1.4% |
| Dysuria |
1.4% |
| Intraocular Pressure Increased |
1.4% |
| Parkinson's Disease |
1.4% |
| Anaemia |
0.7% |
| Atrial Fibrillation |
0.7% |
|
| Hypoglycaemia |
14.3% |
| Renal Failure |
10.0% |
| Hyponatraemia |
7.1% |
| Vomiting |
7.1% |
| Rhabdomyolysis |
5.7% |
| Toxic Skin Eruption |
5.7% |
| Weight Decreased |
5.7% |
| Melaena |
4.3% |
| Pulmonary Arterial Hypertension |
4.3% |
| Pyrexia |
4.3% |
| Urinary Tract Infection |
4.3% |
| Visual Impairment |
4.3% |
| Agranulocytosis |
2.9% |
| Hypoglycaemic Encephalopathy |
2.9% |
| Mydriasis |
2.9% |
| Orthostatic Hypotension |
2.9% |
| Overdose |
2.9% |
| Pancreatitis |
2.9% |
| Pancreatitis Acute |
2.9% |
| Pneumonia |
2.9% |
|
| Concomitant |
| Diabetes Mellitus |
25.9% |
| Hypertension |
18.7% |
| Drug Use For Unknown Indication |
12.0% |
| Type 2 Diabetes Mellitus |
8.4% |
| Product Used For Unknown Indication |
4.7% |
| Rheumatoid Arthritis |
4.1% |
| Prophylaxis |
3.2% |
| Acute Myocardial Infarction |
2.4% |
| Asthma |
2.2% |
| Hypercholesterolaemia |
2.0% |
| Depression |
1.9% |
| Osteoporosis |
1.8% |
| Atrial Fibrillation |
1.7% |
| Hepatic Cirrhosis |
1.7% |
| Hyperlipidaemia |
1.7% |
| Insomnia |
1.7% |
| Angina Pectoris |
1.6% |
| Pleural Mesothelioma Malignant |
1.5% |
| Hepatic Neoplasm Malignant |
1.3% |
| Gastric Ulcer |
1.3% |
|
| Renal Failure Acute |
12.2% |
| White Blood Cell Count Decreased |
9.6% |
| Vomiting |
7.4% |
| Interstitial Lung Disease |
6.4% |
| Renal Failure |
6.4% |
| Weight Decreased |
5.9% |
| Hypoglycaemia |
4.8% |
| Hyponatraemia |
4.3% |
| Osteoporosis |
4.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.3% |
| Urinary Tract Infection |
4.3% |
| Diabetes Mellitus |
3.7% |
| Hepatic Function Abnormal |
3.7% |
| Myocardial Infarction |
3.7% |
| Pneumonia |
3.7% |
| Vitreous Haemorrhage |
3.7% |
| Rhabdomyolysis |
3.2% |
| Weight Increased |
3.2% |
| International Normalised Ratio Increased |
2.7% |
| Malaise |
2.7% |
|
| Interacting |
| Rheumatoid Arthritis |
40.0% |
| Oral Fungal Infection |
16.0% |
| Type 2 Diabetes Mellitus |
16.0% |
| Diabetes Mellitus |
12.0% |
| Peptic Ulcer |
8.0% |
| Asthma |
4.0% |
| Pneumonia Legionella |
4.0% |
|
| Motor Dysfunction |
50.0% |
| Hypoglycaemia |
25.0% |
| Pancytopenia |
25.0% |
|
